Model Informed Drug Development Archives

On-Demand Webinar

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

Learn how a stepwise C-QTc approach can streamline cardiac safety evaluation, reduce costs, and align…

CertaraMay 5, 2025

Press Coverage

FDA plans to phase out animal testing requirements

Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…

CertaraApril 10, 2025

On-Demand Webinar

MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants

Explore how model-informed drug development (MIDD) enhanced clinical lactation studies and supported global health policy…

CertaraMarch 28, 2025

Video

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

CertaraMarch 27, 2025

Video

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

CertaraMarch 26, 2025

Video

Behind the Science: Meet Sr. Director Craig Comisar

CertaraMarch 26, 2025

Video

Meet Floris Fauchet: From Model-Based Drug Development to Martial Arts

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

CertaraMarch 24, 2025

Publication

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The IMPAACT 2017/MOCHA study, a phase 1/2 multicenter trial across five countries, assessed the safety,…

CertaraMarch 20, 2025

Press Coverage

How biosimulation and virtual trials can bust through clinical trial roadblocks

Discover how using biosimulation for rare disease drug development can help overcome statistical and recruitment…

CertaraMarch 14, 2025

On-Demand Webinar

Model-Informed Drug Development in the Age of AI

Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…

CertaraMarch 10, 2025

Model Informed Drug Development

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

FDA plans to phase out animal testing requirements

MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

Behind the Science: Meet Sr. Director Craig Comisar

Meet Floris Fauchet: From Model-Based Drug Development to Martial Arts

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

How biosimulation and virtual trials can bust through clinical trial roadblocks

Model-Informed Drug Development in the Age of AI

Newsletter sign up

Quick links

Solutions

Contact